nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—SLC6A2—nerve—acquired immunodeficiency syndrome	0.0207	0.169	CbGeAlD
Bretylium—Paranoia—Efavirenz—acquired immunodeficiency syndrome	0.0157	0.0179	CcSEcCtD
Bretylium—Hiccups—Delavirdine—acquired immunodeficiency syndrome	0.0103	0.0117	CcSEcCtD
Bretylium—Lethargy—Abacavir—acquired immunodeficiency syndrome	0.0102	0.0117	CcSEcCtD
Bretylium—Affect lability—Nelfinavir—acquired immunodeficiency syndrome	0.0101	0.0115	CcSEcCtD
Bretylium—Affect lability—Stavudine—acquired immunodeficiency syndrome	0.01	0.0114	CcSEcCtD
Bretylium—Mood swings—Nelfinavir—acquired immunodeficiency syndrome	0.00968	0.011	CcSEcCtD
Bretylium—Mood swings—Stavudine—acquired immunodeficiency syndrome	0.00965	0.011	CcSEcCtD
Bretylium—ATP1A1—retina—acquired immunodeficiency syndrome	0.00964	0.0789	CbGeAlD
Bretylium—Lightheadedness—Efavirenz—acquired immunodeficiency syndrome	0.00959	0.0109	CcSEcCtD
Bretylium—Hiccups—Ritonavir—acquired immunodeficiency syndrome	0.00948	0.0108	CcSEcCtD
Bretylium—Affect lability—Zidovudine—acquired immunodeficiency syndrome	0.00871	0.00993	CcSEcCtD
Bretylium—ATP1A1—skin of body—acquired immunodeficiency syndrome	0.00846	0.0692	CbGeAlD
Bretylium—Mood swings—Zidovudine—acquired immunodeficiency syndrome	0.00839	0.00955	CcSEcCtD
Bretylium—Lightheadedness—Saquinavir—acquired immunodeficiency syndrome	0.00816	0.0093	CcSEcCtD
Bretylium—Conjunctivitis—Nevirapine—acquired immunodeficiency syndrome	0.0079	0.009	CcSEcCtD
Bretylium—Affect lability—Efavirenz—acquired immunodeficiency syndrome	0.00766	0.00872	CcSEcCtD
Bretylium—Conjunctivitis—Stavudine—acquired immunodeficiency syndrome	0.00763	0.00869	CcSEcCtD
Bretylium—Psychotic disorder—Efavirenz—acquired immunodeficiency syndrome	0.0076	0.00865	CcSEcCtD
Bretylium—Lethargy—Delavirdine—acquired immunodeficiency syndrome	0.00759	0.00865	CcSEcCtD
Bretylium—Conjunctivitis—Abacavir—acquired immunodeficiency syndrome	0.00752	0.00856	CcSEcCtD
Bretylium—Sweating increased—Zidovudine—acquired immunodeficiency syndrome	0.00745	0.00849	CcSEcCtD
Bretylium—Mood swings—Efavirenz—acquired immunodeficiency syndrome	0.00737	0.00839	CcSEcCtD
Bretylium—Affect lability—Delavirdine—acquired immunodeficiency syndrome	0.00733	0.00835	CcSEcCtD
Bretylium—Mood swings—Delavirdine—acquired immunodeficiency syndrome	0.00705	0.00803	CcSEcCtD
Bretylium—Angina pectoris—Indinavir—acquired immunodeficiency syndrome	0.00693	0.0079	CcSEcCtD
Bretylium—ATP1A1—lymphoid tissue—acquired immunodeficiency syndrome	0.00685	0.0561	CbGeAlD
Bretylium—Orthostatic hypotension—Delavirdine—acquired immunodeficiency syndrome	0.0068	0.00774	CcSEcCtD
Bretylium—Affect lability—Ritonavir—acquired immunodeficiency syndrome	0.00677	0.00772	CcSEcCtD
Bretylium—ATP1A1—digestive system—acquired immunodeficiency syndrome	0.00677	0.0554	CbGeAlD
Bretylium—Lethargy—Saquinavir—acquired immunodeficiency syndrome	0.00676	0.0077	CcSEcCtD
Bretylium—Sweating increased—Efavirenz—acquired immunodeficiency syndrome	0.00655	0.00746	CcSEcCtD
Bretylium—Mood swings—Ritonavir—acquired immunodeficiency syndrome	0.00652	0.00743	CcSEcCtD
Bretylium—Psychotic disorder—Saquinavir—acquired immunodeficiency syndrome	0.00647	0.00737	CcSEcCtD
Bretylium—ATP1A1—blood—acquired immunodeficiency syndrome	0.00645	0.0528	CbGeAlD
Bretylium—Orthostatic hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00629	0.00716	CcSEcCtD
Bretylium—Sweating increased—Delavirdine—acquired immunodeficiency syndrome	0.00627	0.00714	CcSEcCtD
Bretylium—ATP1A1—bone marrow—acquired immunodeficiency syndrome	0.00624	0.051	CbGeAlD
Bretylium—Affect lability—Lamivudine—acquired immunodeficiency syndrome	0.00622	0.00709	CcSEcCtD
Bretylium—ATP1A1—spinal cord—acquired immunodeficiency syndrome	0.00621	0.0508	CbGeAlD
Bretylium—Mood swings—Lamivudine—acquired immunodeficiency syndrome	0.00599	0.00682	CcSEcCtD
Bretylium—ATP1A1—vagina—acquired immunodeficiency syndrome	0.00598	0.0489	CbGeAlD
Bretylium—ATP1A1—lung—acquired immunodeficiency syndrome	0.00565	0.0462	CbGeAlD
Bretylium—Sweating increased—Saquinavir—acquired immunodeficiency syndrome	0.00558	0.00635	CcSEcCtD
Bretylium—Conjunctivitis—Delavirdine—acquired immunodeficiency syndrome	0.00557	0.00635	CcSEcCtD
Bretylium—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.00543	0.00618	CcSEcCtD
Bretylium—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.00532	0.00606	CcSEcCtD
Bretylium—Flushing—Indinavir—acquired immunodeficiency syndrome	0.00529	0.00602	CcSEcCtD
Bretylium—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.00524	0.00597	CcSEcCtD
Bretylium—ATP1A1—nervous system—acquired immunodeficiency syndrome	0.00524	0.0428	CbGeAlD
Bretylium—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.00522	0.00595	CcSEcCtD
Bretylium—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.0052	0.00593	CcSEcCtD
Bretylium—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00517	0.00589	CcSEcCtD
Bretylium—Conjunctivitis—Ritonavir—acquired immunodeficiency syndrome	0.00516	0.00587	CcSEcCtD
Bretylium—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.00513	0.00584	CcSEcCtD
Bretylium—ATP1A1—central nervous system—acquired immunodeficiency syndrome	0.00504	0.0412	CbGeAlD
Bretylium—SLC6A2—lung—acquired immunodeficiency syndrome	0.00502	0.0411	CbGeAlD
Bretylium—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.005	0.0057	CcSEcCtD
Bretylium—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00499	0.00569	CcSEcCtD
Bretylium—Conjunctivitis—Saquinavir—acquired immunodeficiency syndrome	0.00496	0.00565	CcSEcCtD
Bretylium—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00485	0.00553	CcSEcCtD
Bretylium—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00484	0.00551	CcSEcCtD
Bretylium—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00479	0.00546	CcSEcCtD
Bretylium—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.00478	0.00545	CcSEcCtD
Bretylium—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00471	0.00537	CcSEcCtD
Bretylium—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.00469	0.00534	CcSEcCtD
Bretylium—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.00465	0.0381	CbGeAlD
Bretylium—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00456	0.00519	CcSEcCtD
Bretylium—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00456	0.00519	CcSEcCtD
Bretylium—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.00452	0.00515	CcSEcCtD
Bretylium—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.00448	0.0366	CbGeAlD
Bretylium—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00448	0.0051	CcSEcCtD
Bretylium—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00445	0.00507	CcSEcCtD
Bretylium—Syncope—Indinavir—acquired immunodeficiency syndrome	0.00445	0.00507	CcSEcCtD
Bretylium—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00442	0.00503	CcSEcCtD
Bretylium—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.0044	0.00501	CcSEcCtD
Bretylium—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00439	0.005	CcSEcCtD
Bretylium—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.00436	0.00496	CcSEcCtD
Bretylium—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00433	0.00493	CcSEcCtD
Bretylium—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00428	0.00488	CcSEcCtD
Bretylium—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00427	0.00487	CcSEcCtD
Bretylium—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00424	0.00483	CcSEcCtD
Bretylium—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00421	0.00479	CcSEcCtD
Bretylium—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00421	0.00479	CcSEcCtD
Bretylium—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00421	0.00479	CcSEcCtD
Bretylium—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.0042	0.00479	CcSEcCtD
Bretylium—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00414	0.00471	CcSEcCtD
Bretylium—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.00412	0.00469	CcSEcCtD
Bretylium—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00411	0.00468	CcSEcCtD
Bretylium—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.0041	0.00467	CcSEcCtD
Bretylium—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.0041	0.00467	CcSEcCtD
Bretylium—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00409	0.00466	CcSEcCtD
Bretylium—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00406	0.00463	CcSEcCtD
Bretylium—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00404	0.00461	CcSEcCtD
Bretylium—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00403	0.00459	CcSEcCtD
Bretylium—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00403	0.00459	CcSEcCtD
Bretylium—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00402	0.00458	CcSEcCtD
Bretylium—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00402	0.00458	CcSEcCtD
Bretylium—ATP1A1—brain—acquired immunodeficiency syndrome	0.004	0.0327	CbGeAlD
Bretylium—Shock—Indinavir—acquired immunodeficiency syndrome	0.00398	0.00454	CcSEcCtD
Bretylium—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00397	0.00453	CcSEcCtD
Bretylium—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00397	0.00452	CcSEcCtD
Bretylium—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00397	0.00452	CcSEcCtD
Bretylium—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00396	0.00451	CcSEcCtD
Bretylium—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00396	0.00451	CcSEcCtD
Bretylium—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00394	0.00449	CcSEcCtD
Bretylium—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00394	0.00449	CcSEcCtD
Bretylium—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00391	0.00446	CcSEcCtD
Bretylium—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.0039	0.00444	CcSEcCtD
Bretylium—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.0039	0.00444	CcSEcCtD
Bretylium—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00388	0.00442	CcSEcCtD
Bretylium—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00387	0.00441	CcSEcCtD
Bretylium—ATP1A1—lymph node—acquired immunodeficiency syndrome	0.00387	0.0316	CbGeAlD
Bretylium—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00385	0.00439	CcSEcCtD
Bretylium—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.0038	0.00433	CcSEcCtD
Bretylium—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00376	0.00428	CcSEcCtD
Bretylium—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00376	0.00428	CcSEcCtD
Bretylium—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00372	0.00424	CcSEcCtD
Bretylium—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00372	0.00423	CcSEcCtD
Bretylium—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.0037	0.00421	CcSEcCtD
Bretylium—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00369	0.0042	CcSEcCtD
Bretylium—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00367	0.00418	CcSEcCtD
Bretylium—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00364	0.00415	CcSEcCtD
Bretylium—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00361	0.00411	CcSEcCtD
Bretylium—Shock—Delavirdine—acquired immunodeficiency syndrome	0.0036	0.0041	CcSEcCtD
Bretylium—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00359	0.00408	CcSEcCtD
Bretylium—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00358	0.00408	CcSEcCtD
Bretylium—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00358	0.00408	CcSEcCtD
Bretylium—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00358	0.00408	CcSEcCtD
Bretylium—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00356	0.00405	CcSEcCtD
Bretylium—SLC6A2—brain—acquired immunodeficiency syndrome	0.00356	0.0291	CbGeAlD
Bretylium—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00355	0.00404	CcSEcCtD
Bretylium—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00354	0.00403	CcSEcCtD
Bretylium—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00352	0.00401	CcSEcCtD
Bretylium—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00351	0.00399	CcSEcCtD
Bretylium—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00344	0.00392	CcSEcCtD
Bretylium—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00344	0.00392	CcSEcCtD
Bretylium—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00344	0.00392	CcSEcCtD
Bretylium—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.00344	0.0281	CbGeAlD
Bretylium—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00344	0.00391	CcSEcCtD
Bretylium—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00342	0.0039	CcSEcCtD
Bretylium—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00342	0.0039	CcSEcCtD
Bretylium—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00342	0.0039	CcSEcCtD
Bretylium—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00341	0.00389	CcSEcCtD
Bretylium—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00341	0.00389	CcSEcCtD
Bretylium—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00341	0.00388	CcSEcCtD
Bretylium—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00338	0.00386	CcSEcCtD
Bretylium—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00337	0.00384	CcSEcCtD
Bretylium—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00334	0.00381	CcSEcCtD
Bretylium—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00333	0.0038	CcSEcCtD
Bretylium—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00333	0.00379	CcSEcCtD
Bretylium—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00332	0.00378	CcSEcCtD
Bretylium—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00331	0.00377	CcSEcCtD
Bretylium—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00331	0.00377	CcSEcCtD
Bretylium—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.0033	0.00376	CcSEcCtD
Bretylium—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00328	0.00374	CcSEcCtD
Bretylium—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00327	0.00373	CcSEcCtD
Bretylium—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00326	0.00372	CcSEcCtD
Bretylium—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00326	0.00372	CcSEcCtD
Bretylium—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00323	0.00368	CcSEcCtD
Bretylium—Shock—Saquinavir—acquired immunodeficiency syndrome	0.0032	0.00365	CcSEcCtD
Bretylium—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.0032	0.00364	CcSEcCtD
Bretylium—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.0032	0.00364	CcSEcCtD
Bretylium—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00319	0.00364	CcSEcCtD
Bretylium—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00318	0.00363	CcSEcCtD
Bretylium—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00315	0.00359	CcSEcCtD
Bretylium—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00315	0.00359	CcSEcCtD
Bretylium—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00314	0.00357	CcSEcCtD
Bretylium—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00313	0.00357	CcSEcCtD
Bretylium—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00313	0.00356	CcSEcCtD
Bretylium—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00308	0.00351	CcSEcCtD
Bretylium—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00306	0.00348	CcSEcCtD
Bretylium—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00302	0.00344	CcSEcCtD
Bretylium—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00302	0.00344	CcSEcCtD
Bretylium—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00302	0.00344	CcSEcCtD
Bretylium—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00301	0.00343	CcSEcCtD
Bretylium—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.003	0.00342	CcSEcCtD
Bretylium—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00299	0.00341	CcSEcCtD
Bretylium—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00298	0.0034	CcSEcCtD
Bretylium—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00298	0.00339	CcSEcCtD
Bretylium—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00297	0.00339	CcSEcCtD
Bretylium—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00293	0.00334	CcSEcCtD
Bretylium—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.0029	0.00331	CcSEcCtD
Bretylium—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00289	0.00329	CcSEcCtD
Bretylium—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00289	0.00329	CcSEcCtD
Bretylium—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00288	0.00328	CcSEcCtD
Bretylium—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00279	0.00318	CcSEcCtD
Bretylium—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00277	0.00315	CcSEcCtD
Bretylium—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00277	0.00315	CcSEcCtD
Bretylium—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00277	0.00315	CcSEcCtD
Bretylium—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00277	0.00315	CcSEcCtD
Bretylium—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00268	0.00306	CcSEcCtD
Bretylium—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00268	0.00305	CcSEcCtD
Bretylium—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00267	0.00305	CcSEcCtD
Bretylium—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00267	0.00305	CcSEcCtD
Bretylium—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00266	0.00303	CcSEcCtD
Bretylium—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00262	0.00298	CcSEcCtD
Bretylium—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00258	0.00294	CcSEcCtD
Bretylium—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00257	0.00293	CcSEcCtD
Bretylium—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00257	0.00293	CcSEcCtD
Bretylium—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00257	0.00293	CcSEcCtD
Bretylium—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00256	0.00292	CcSEcCtD
Bretylium—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00254	0.00289	CcSEcCtD
Bretylium—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00253	0.00288	CcSEcCtD
Bretylium—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.0025	0.00285	CcSEcCtD
Bretylium—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00246	0.0028	CcSEcCtD
Bretylium—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00246	0.0028	CcSEcCtD
Bretylium—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00243	0.00277	CcSEcCtD
Bretylium—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00242	0.00276	CcSEcCtD
Bretylium—Nausea—Indinavir—acquired immunodeficiency syndrome	0.0024	0.00274	CcSEcCtD
Bretylium—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00233	0.00265	CcSEcCtD
Bretylium—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00231	0.00264	CcSEcCtD
Bretylium—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00227	0.00259	CcSEcCtD
Bretylium—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00224	0.00255	CcSEcCtD
Bretylium—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00223	0.00254	CcSEcCtD
Bretylium—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00217	0.00248	CcSEcCtD
Bretylium—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00215	0.00245	CcSEcCtD
Bretylium—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00215	0.00245	CcSEcCtD
Bretylium—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00213	0.00242	CcSEcCtD
Bretylium—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00207	0.00236	CcSEcCtD
Bretylium—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00205	0.00234	CcSEcCtD
Bretylium—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00201	0.00229	CcSEcCtD
Bretylium—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00197	0.00225	CcSEcCtD
Bretylium—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00193	0.0022	CcSEcCtD
Bretylium—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00184	0.0021	CcSEcCtD
